AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 32.910
- +0.180+0.55%
Close Mar 21 16:00 ET
- 32.910
- 0.0000.00%
Post 16:14 ET
5.23BMarket Cap-10.83P/E (TTM)
33.620High32.301Low2.00MVolume32.710Open32.730Pre Close65.88MTurnover1.27%Turnover RatioLossP/E (Static)158.96MShares52.34052wk High8.89P/B5.19BFloat Cap30.23052wk Low--Dividend TTM157.59MShs Float86.582Historical High--Div YieldTTM4.03%Amplitude2.500Historical Low32.952Avg Price1Lot Size
About Ionis Pharmaceuticals Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Company Profile
SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees1069
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200
Websitehttp://www.ionis.com
Company Executives
- Name
- Position
- Salary
- Dr. Brett P. Monia, PhD
- Chief Executive Officer and Director
- 12.50M
- Patrick R. O'Neil, Esq.
- Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
- --
- Joseph T. Baroldi
- Executive Vice President and Chief Business Officer
- --
- Shannon L. Devers
- Executive Vice President and Chief Human Resources Officer
- --
- Eugene Schneider
- Executive Vice President and Chief Clinical Development and Operations Officer
- --
- Kyle Jenne
- Executive Vice President and Chief Global Product Strategy Officer
- --
- Dr. Richard S. Geary,PhD
- Executive Vice President and Chief Development Officer
- 2.56M
- Dr. C. Frank Bennett,PhD
- Executive Vice President and Chief Scientific Officer
- --
- Elizabeth L. Hougen
- Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 2.89M
- Brian Birchler
- Executive Vice President, Corporate and Development Operations
- --
- Eric E. Swayze, PhD
- Executive Vice President, Research
- 2.56M
- Dr. Joseph Loscalzo, M.D.,PhD
- Chairman of the Board
- 568.04K
- B. Lynne Parshall, Esq.,J.D.
- Director
- 538.04K
- Michael J. Yang
- Independent Director
- 363.05K
- Joseph Klein, III
- Independent Director
- 542.04K
- Dr. Michael Hayden
- Independent Director
- 528.04K
- Joan E. Herman
- Independent Director
- 540.04K
- Joseph H. Wender
- Lead Independent Director
- 598.04K
- Allene M. Diaz
- Independent Director
- 530.04K
- Dr. Spencer R. Berthelsen,M.D.
- Independent Director
- 548.04K